Volume 12, Number 8—August 2006
Salmonella Typhimurium DT104, Italy
To the Editor: The recent article by Helms et al. described the distribution of Salmonella enterica serovar Typhimurium definitive page type 104 (DT104) infections in 29 countries from 1992 to 2001 (1). Results from Italy were not presented because routine phage typing was not performed before 2001. Since 2002, circulation of S. Typhimurium phage types has been monitored by the laboratory-based surveillance system Enter-net Italia, which was coordinated by Istituto Superiore di Sanità as part of the European network for the surveillance of foodborne infections (2). From 2000 to 2004, S. Typhimurium accounted for ≈40% of all human Salmonella isolates each year. Since 2002, ≈20% of the S. Typhimurium isolates were identified as DT104, and all had a pentavalent resistance pattern (resistance to ampicillin, chloramphenicol, streptomycin, sulfonamides, and tetracycline) (3). Although the results reported by Helms et al. (1) refer to a different period (1992–2001), the Italian data are similar to those from many other countries in northern and western Europe.
According to the Colindale scheme for phage typing (4 and L.R. Ward, pers. comm.), numerous distinguishable DT104 subtypes can be identified as DT104 A, B, C, H, and L. Most (90%) S. Typhimurium DT104 strains isolated during the last 2 years belonged to subtype DT104L.
Emergence of phage subtype DT104A was identified in June 2004 during an outbreak of salmonellosis in Rome. This subtype had never been previously identified in Italy. All DT104A isolates were susceptible to the Enter-net panel of antimicrobial drugs (2), a feature unusual for S. Typhimurium (5). A total of 63 cases were confirmed; 61 were from Rome, and 2 were from a neighboring region. All isolates had similar pulsed-field gel electrophoretic profiles when analyzed with the Salm-gene protocol (6). Since the outbreak, 1 additional human isolate of DT104A was identified from a resident of the same neighboring region. This isolate was also susceptible to the panel of antimicrobial drugs. A fermented pork salami was epidemiologically implicated as the vehicle of infection. No microbiologic evidence was found because no food samples were available when the outbreak was recognized.
The incidence of DT104 in Italy has remained stable from 2002 through 2004. However, emergence of subtype DT104A during a recent outbreak highlights the need for subtyping in identifying communitywide outbreaks and in monitoring changing subtype patterns.
- Helms M, Ethelberg S, Mølbak K. DT104 Study Group. International Salmonella Typhimurium DT104 infections, 1992–2001. Emerg Infect Dis. 2005;11:859–67.
- Enter-net. International surveillance network for the enteric infections Salmonella and VTEC O157. [cited 2006 May 12]. Available from http://www.hpa.org.uk/hpa/inter/enter-net_menu.htm
- Busani L, Graziani C, Battisti A, Franco A, Ricci A, Vio D, Antibotic resistance in Salmonella enterica serotypes Typhimurium, Enteritidis and Infantis from human infections foodstuffs and farm animals in Italy. Epidemiol Infect. 2004;132:245–51.
- Anderson ES, Ward LR, De Saxe MJ, Old DC, Barker R, Duguid JP. Bacteriophage-typing designations of Salmonella Typhimurium. J Hyg (Lond). 1977;78:297–300.
- Malorny B, Schroeter A, Bunge C, Helmuth R. Prevalence of Escherichia coli O157:H7 prophage-like sequences among German Salmonella enterica serotype Typhimurium phage types and their use in detection of phage type DT104 by polymerase chain reaction. Vet Microbiol. 2002;87:253–65.
- Peters TM, Maguire C, Threlfall EJ, Fisher IST, Gill N, Gatto AJ. on behalf of the Salm-gene project participants. The Salm-gene project–a European collaboration for DNA fingerprinting for food-related salmonellosis. Euro Surveill. 2003;8:46–50.
Suggested citation for this article: Cawthorne A, Galetta P, Massari M, Dionisi AM, Filetici E, Luzzi I. Salmonella Typhimurium DT104, Italy [letter]. Emerg Infect Dis [serial on the Internet]. 2006 Aug [date cited]. http://dx.doi.org/10.3201/eid1208.050968
Please use the form below to submit correspondence to the authors or contact them at the following address:
Amy Cawthorne, European Programme for Intervention Epidemiology Training, Istituto Superiore di Sanità, Centro Nazionale di Epidemiologia, Sorveglianza e Promozione della Salute, Reparto di Epidemiologia delle Malattie Infettive, Viale Regina Elena 299, 00161 Rome, Italy
Comment submitted successfully, thank you for your feedback.
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
- Page created: December 09, 2011
- Page last updated: December 09, 2011
- Page last reviewed: December 09, 2011
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)